 Boston Scientific Corp received a subpoena on July  from the US Attorney for the District of New Jersey concerning Bridgepoint Medical Inc a cardiology products company it acquired in October  The subpoena disclosed in Boston Scientifics quarterly report filed with the Securities and Exchange Commission seeks information on sales of CrossBoss and Stingray products related educational and training activities and the acquisition